Hepatitis price war draws Blue Cross coverage for both drugs
By Robert LangrethPrime Therapeutics manages pharmacy benefits for 25 million patients in 23 states.
January 09, 2015
How OPEC Weaponized the Price of Oil Against U.S. DrillersIf there ever was doubt about the strategy of OPEC, its wealthiest members are putting that issue to rest.
January 08, 2015
Schwab's Sonders: Moody Market Means Opportunity for AdvisorsInvestors need support to contain their urge to panic when the equity markets dip, the Schwab expert says.
January 08, 2015
New Buyers Will Flow Into Housing Market in 2015: ForecastYounger buyers will drive much of the housing market's growth as the job market improves, Realtor.com says.
January 07, 2015
Optimistic Fed Said Rate Rise Unlikely Before AprilThe Fed confirmed that being patient on interest rates means no increase before late April.
January 07, 2015
VIP drug-approval pass costs $125 million and climbingHow do regulatory delays affect health care costs? Priority-review vouchers offer a clue.
January 07, 2015
VIP drug-approval pass costs $125 million and climbingHow do regulatory delays affect health care costs? Priority-review vouchers offer a clue.
January 06, 2015
Gilead makes exclusive deal with CVS for hepatitis C drugsA big pharmacy benefits managers got a discount from the maker of a new competitor.